Free Trial

Procter & Gamble (PG) Stock Forecast & Price Target

Procter & Gamble logo
$165.98 -1.43 (-0.85%)
Closing price 01/31/2025 03:59 PM Eastern
Extended Trading
$165.72 -0.25 (-0.15%)
As of 01/31/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Procter & Gamble - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
7
Buy
15

Based on 22 Wall Street analysts who have issued ratings for Procter & Gamble in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 22 analysts, 7 have given a hold rating, 13 have given a buy rating, and 2 have given a strong buy rating for PG.

Consensus Price Target

$180.53
8.76% Upside
According to the 22 analysts' twelve-month price targets for Procter & Gamble, the average price target is $180.53. The highest price target for PG is $209.00, while the lowest price target for PG is $159.00. The average price target represents a forecasted upside of 8.76% from the current price of $165.98.
Get the Latest News and Ratings for PG and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Procter & Gamble and its competitors.

Sign Up

PG Analyst Ratings Over Time

TypeCurrent Forecast
2/2/24 to 2/1/25
1 Month Ago
1/3/24 to 1/2/25
3 Months Ago
11/4/23 to 11/3/24
1 Year Ago
2/2/23 to 2/2/24
Strong Buy
2 Strong Buy rating(s)
2 Strong Buy rating(s)
2 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
13 Buy rating(s)
14 Buy rating(s)
13 Buy rating(s)
12 Buy rating(s)
Hold
7 Hold rating(s)
7 Hold rating(s)
8 Hold rating(s)
6 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$180.53$180.45$177.00$167.06
Forecasted Upside8.76% Upside8.72% Upside7.21% Upside5.67% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

PG Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

PG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Procter & Gamble Stock vs. The Competition

TypeProcter & GambleConsumer Staples CompaniesS&P 500
Consensus Rating Score
2.77
2.49
2.53
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside8.76% Upside36.67% Upside12.26% Upside
News Sentiment Rating
Positive News

See Recent PG News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/23/2025Royal Bank of Canada
4 of 5 stars
Nik Modi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform$164.00 ➝ $164.00-0.81%
1/23/2025Stifel Nicolaus
4 of 5 stars
Mark Astrachan
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetHold ➝ Hold$161.00 ➝ $165.00+0.60%
1/23/2025Wells Fargo & Company
3 of 5 stars
Chris Carey
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$176.00 ➝ $180.00+9.38%
1/23/2025Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
L. Lieberman
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetEqual Weight ➝ Equal Weight$155.00 ➝ $159.00-3.38%
1/23/2025DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
L. Weiser
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$209.00 ➝ $209.00+27.00%
1/16/2025UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Peter Grom
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$196.00 ➝ $189.00+17.83%
1/16/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Andrea Teixeira
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$186.00 ➝ $181.00+13.37%
10/21/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$174.00 ➝ $191.00+12.88%
10/21/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$180.00 ➝ $183.00+8.25%
10/4/2024Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Zamacona
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
9/24/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$174.00+0.13%
8/29/2024DZ Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$190.00+12.36%
8/23/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
G. Badishkanian
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
8/1/2024Dbs Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C. Widjaja
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
7/24/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$182.00 ➝ $175.00+5.03%
7/23/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Moskow
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$189.00+12.31%
7/17/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$171.00 ➝ $176.00+4.13%
7/10/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$177.00 ➝ $190.00+13.96%
6/24/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
K. Grundy
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$187.00+11.14%
4/25/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$180.00 ➝ $185.00+13.49%
3/11/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$160.00 ➝ $175.00+9.14%
3/1/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$168.00+5.70%
1/24/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$170.00 ➝ $175.00+13.65%
10/12/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetMarket Perform ➝ Market Perform$162.00 ➝ $153.00+7.02%
9/22/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$179.00+17.64%
9/8/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Andersen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Perform
8/1/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$170.00 ➝ $175.00+11.96%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 10:24 AM ET.


Should I Buy Procter & Gamble Stock? PG Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, January 25, 2025. Please send any questions or comments about these Procter & Gamble pros and cons to contact@marketbeat.com.

Procter & Gamble
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Procter & Gamble:

  • Procter & Gamble's stock price is currently at $164.17, showing resilience in a fluctuating market, which may indicate stability and potential for growth.
  • The company has received multiple recent upgrades from analysts, with target prices raised by firms like Barclays and Morgan Stanley, suggesting positive sentiment and confidence in future performance.
  • Procter & Gamble reported a quarterly revenue of $21.88 billion, exceeding analysts' expectations, which reflects strong operational performance and demand for its products.
  • The firm has a solid market capitalization of $387.20 billion, indicating its significant presence and stability in the consumer goods sector, which can be attractive for long-term investors.
  • With a current ratio of 0.76 and a quick ratio of 0.55, Procter & Gamble demonstrates a reasonable ability to meet short-term liabilities, which is crucial for financial health.

Procter & Gamble
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Procter & Gamble for these reasons:

  • The stock has shown a slight decline of 0.3% recently, which may indicate potential volatility and investor uncertainty in the short term.
  • Procter & Gamble has a price-to-earnings ratio of 26.18, which is relatively high, suggesting that the stock may be overvalued compared to its earnings, potentially limiting upside for new investors.
  • Analysts have issued mixed ratings, with some maintaining a "hold" rating, indicating that not all experts are confident in the stock's immediate growth prospects.
  • The company's debt-to-equity ratio of 0.49, while manageable, suggests that it is not entirely free from debt, which could pose risks if market conditions worsen.
  • Recent trading volumes have been significantly lower than average, which may indicate reduced investor interest and could lead to increased volatility in the stock price.

PG Forecast - Frequently Asked Questions

According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for Procter & Gamble is $180.53, with a high forecast of $209.00 and a low forecast of $159.00.

22 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Procter & Gamble in the last twelve months. There are currently 7 hold ratings, 13 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" PG shares.

According to analysts, Procter & Gamble's stock has a predicted upside of 8.76% based on their 12-month stock forecasts.

Over the previous 90 days, Procter & Gamble's stock had 1 upgrade by analysts.

Procter & Gamble has been rated by research analysts at Barclays, DA Davidson, JPMorgan Chase & Co., Royal Bank of Canada, Stifel Nicolaus, UBS Group, and Wells Fargo & Company in the past 90 days.

Analysts like Procter & Gamble more than other "consumer staples" companies. The consensus rating for Procter & Gamble is Moderate Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how PG compares to other companies.


This page (NYSE:PG) was last updated on 2/1/2025 by MarketBeat.com Staff
From Our Partners